Table 2.
Basic information table of included literature.
| Author | Publication years | Intervention methods | Number of cases | Age | Course of treatment | Outcome indicators |
|---|---|---|---|---|---|---|
| Xu Huaming (14) | 2006 | AvsB | 51 ploidy | 45 | 21d | Efficacy |
| Qin He (15) | 2016 | AvsC | 40,40 | 60.35 ± 8.82, 57.80 ± 7.14 | 10d | Efficacy |
| Wang Yingjie (16) | 2016 | AvsB | 50, 50 | 40.0 ± 4.1, 39.0 ± 5.2 | 14d | Efficacy, AE |
| Peng Jiping (17) | 2019 | AvsB | 60, 60 | 49.65 ± 3.52, 47.16 ± 5.56 | 7d | Efficacy |
| Yang Yongguang (18) | 2015 | AvsB | 90, living | 25–70 | 10d | Efficacy |
| Yuan Zhiqi (19) | 2018 | AvsB | 47 and | 38.64 ± 5.31, 38.55 ± 5.43 | 14d | Efficacy |
| Yuan Xingxing (20) | 2017 | AvsC | 80,80 | 43.60 ± 6.24, 40.78 ± 6.67 | 10d | Efficacy |
| Li Wanying (21) | 2020 | AvsC | 32, 32 | 32.78 ± 7.67, 38 ± −6.68 | 14d | Efficacy, VAS |
| Li Jianhua (22) | 2020 | AvsB | 42 and | 36.14 ± 5.37, 36.22 ± 6.01 | 21d | Efficacy |
| Yang Jiangxia (23) | 2020 | AvsB | 40,40 | 49.00 ± 1.96, 49.00 ± 1.96 | 21d | Efficacy, VAS, ODI, JOA |
| Huang Saizhi (24) | 2015 | AvsC | 51, 50 | 40.1 ± 6.7, 40.5 ± 5.4 | 10d | Efficacy |
| Sun Chuang (25) | 2019 | AvsB | 38, 38 | 41.4 ± −6.2, 41.5 ± 6.5 | 21d | Efficacy |
| Li Changsheng (26) | 2011 | AvsB | 46, 50 | 45 | 30d | Efficacy |
| Xiang Changyun (27) | 2015 | AvsB | 40,40 | 32 ± 3.4 | 10d | Efficacy |
| Zhang Jichen (28) | 2011 | AvsB | 40,40 | 41 ± 8, 38 ± 6 | 10d | Efficacy |
| Huang Yucong (29) | 2019 | AvsB | 40,40 | 52.31 ± 10.24, 49.35 ± 10.25 | 10d | Efficacy |
| Zeng Fangang (30) | 2024 | AvsE | 30, 30 | 32.91 ± −4.37, 33.08 ± 4.45 | 60d | Efficacy, VAS, JOA |
| Chen Chunli (31) | 2022 | AvsB | 30, 30 | 40.2 ± 8.3, 40.8 ± 7.8 | 14d | Efficacy, VAS, |
| Chen Wenjing (32) | 2023 | AvsB | 41 9 | 41.85 ± 5.76, 41.37 ± 5.83 | 21d | Efficacy, ODI, AE |
| Chen Yunyao (33) | 2024 | AvsD | 40,40 | 35.20 ± 8.04, 35.85 ± 8.16 | 14d | Efficacy, VAS, ODI |
| Cheng Hui (34) | 2024 | AvsD | 30, 30 | 43.30 ± 13.77, 43.1313.20 | 21d | VAS, ODI |
| Fan Shaoting (35) | 2024 | AvsB | 32, 32 | 49.78 ± 8.25, 50.28 ± 9.03 | Efficacy, VAS, JOA, AE | |
| Hu Chaying (36) | 2025 | AvsF | 35, 35 | 37.49 ± 5.21, 36.95 ± 5.35 | 21d | Efficacy, VAS, JOA |
| Jia Ming (37) | 2023 | AvsC | 50, 50 | 55.8 ± 4.2, 56.6 ± 3.8 | 10d | Efficacy, VAS, JOA |
| Li Bowen (38) | 2023 | AvsB | 38, 38 | 39.70 ± 3.13, 40.164.09 | 14d | Efficacy, VAS, ODI |
| Li Hongpeng (39) | 2024 | AvsB | 50, 50 | 53.42 ± 9.15, 52.96 ± 9.18 | VAS | |
| Meng Xianyu (40) | 2023 | AvsB | 30, 30 | 54.70 ± 17.29, 52.10 ± 13.12 | 21d | Efficacy, ODI, JOA |
| Wang Ling (41) | 2023 | AvsB | 39 July | 40.61 ± 3.65, 40.78 ± 2.45 | 14d | Efficacy, ODI |
| Xiao Ju (42) | 2024 | AvsB | 30, 30 | 53.98 ± 10.11, 53.78 ± 10.78 | 14d | Efficacy, ODI |
| Yuan Baohua (43) | 2024 | AvsB | 35, 35 | 23.63 ± 5.12, 24.57 ± 5.52 | 14d | VAS, ODI |
| Zhao Qi (44) | 2024 | AvsB | 60, 60 | 46.89 ± 5.87, 47.09 ± 5.96 | 28d | Efficacy, ODI, VAS |
| Zheng Liming (45) | 2023 | AvsF | 33,33 | 38.8 ± 7.6, 38.1 ± 6.2 | 28d | JOA, ODI, VAS |
A: Fu’s subcutaneous needling; B:filiform needle; C: electroacupuncture; D: medicine; E: shock wave; F: recovery.